1. Home
  2. BBCP vs ALT Comparison

BBCP vs ALT Comparison

Compare BBCP & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBCP
  • ALT
  • Stock Information
  • Founded
  • BBCP 1983
  • ALT 1997
  • Country
  • BBCP United States
  • ALT United States
  • Employees
  • BBCP N/A
  • ALT N/A
  • Industry
  • BBCP Engineering & Construction
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBCP Consumer Discretionary
  • ALT Health Care
  • Exchange
  • BBCP Nasdaq
  • ALT Nasdaq
  • Market Cap
  • BBCP 360.0M
  • ALT 292.0M
  • IPO Year
  • BBCP 2017
  • ALT N/A
  • Fundamental
  • Price
  • BBCP $7.64
  • ALT $3.78
  • Analyst Decision
  • BBCP Buy
  • ALT Strong Buy
  • Analyst Count
  • BBCP 2
  • ALT 6
  • Target Price
  • BBCP $7.25
  • ALT $17.40
  • AVG Volume (30 Days)
  • BBCP 80.6K
  • ALT 3.0M
  • Earning Date
  • BBCP 09-04-2025
  • ALT 08-12-2025
  • Dividend Yield
  • BBCP N/A
  • ALT N/A
  • EPS Growth
  • BBCP N/A
  • ALT N/A
  • EPS
  • BBCP 0.16
  • ALT N/A
  • Revenue
  • BBCP $395,562,000.00
  • ALT $20,000.00
  • Revenue This Year
  • BBCP N/A
  • ALT N/A
  • Revenue Next Year
  • BBCP $4.28
  • ALT $761,880.20
  • P/E Ratio
  • BBCP $46.78
  • ALT N/A
  • Revenue Growth
  • BBCP N/A
  • ALT N/A
  • 52 Week Low
  • BBCP $4.78
  • ALT $2.90
  • 52 Week High
  • BBCP $9.68
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • BBCP 66.41
  • ALT 50.80
  • Support Level
  • BBCP $6.70
  • ALT $3.54
  • Resistance Level
  • BBCP $7.21
  • ALT $3.84
  • Average True Range (ATR)
  • BBCP 0.24
  • ALT 0.18
  • MACD
  • BBCP 0.02
  • ALT 0.06
  • Stochastic Oscillator
  • BBCP 85.45
  • ALT 85.15

About BBCP Concrete Pumping Holdings Inc.

Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: